Identify oral cancer in its early stages


  Posted by: Dental Design      11th November 2023

Early symptoms of oral cancer can be easily mistaken for other, more common conditions. Because of this, it’s important to remain vigilant and screen each patient during routine examinations.

The BeVigilant™ OraFusion™ System from Vigilant Biosciences® makes this simple.

The non-invasive fluoroscopic and visual saliva biomarker-based semi-quantitative risk assessment tool is able to easily identify the presence of biomarkers associated with oral cancer and produce a report of either low, moderate, or elevated risk levels in 15 minutes or less.

The system is suitable for use as a pre-diagnostic test for symptomatic adults who present with visible abnormalities during the oral cancer exam to help establish their level of risk – helping you to identify oral cancer early, and improve outcomes for your patients.

Please get in touch today for more information.

For more information, please visit or email

No Comments

No comments yet.

Sorry, the comment form is closed at this time.